Drug-Coated Stent Inspection
Ensuring Precision Beyond the Coating Layer
In contemporary cardiovascular device manufacturing, drug-coated stents represent a sophisticated integration of engineering and pharmacology. These devices are designed not only to provide structural support to arteries but also to deliver therapeutic agents that reduce restenosis. While significant attention is given to the coating process itself, an equally critical step often lies just beyond it—inspection of the drug-coated stent.
Drug coating introduces a delicate layer onto an already intricate metallic structure. This layer must remain uniform, intact, and well-adhered while preserving the original geometry of the stent. However, the coating process can subtly influence dimensional characteristics, surface conditions, and overall structural consistency. Even minor deviations at this stage can impact drug distribution, coating adhesion, or expansion behaviour during deployment.
The Challenge of Post-Coating Inspection
Inspecting drug-coated stents is inherently more complex than inspecting bare-metal or electropolished stents. Traditional contact-based measurement methods risk disturbing the coating layer, while visual inspection alone lacks the precision required to detect subtle variations.
Manufacturers must ensure that inspection methods are both non-invasive and highly accurate, capable of evaluating geometry without altering the coated surface. This balance is essential to maintain the integrity of the coating while still achieving reliable quality validation.
Why Geometry Still Matters After Coating
While the focus of drug coating is often on pharmacological performance, the mechanical and geometric integrity of the stent remains equally important. Any distortion, asymmetry, or dimensional inconsistency introduced during coating can affect how the stent expands and interacts with the vessel wall.
Ensuring that the coated stent maintains its intended design parameters is critical not only for product performance but also for regulatory compliance. Inspection at this stage helps confirm that the coating process has not introduced unintended variations.
Moving Toward Non-Contact, Data-Driven Inspection
To address these challenges, manufacturers are increasingly adopting non-contact optical inspection systems. These systems allow for high-resolution evaluation of stent geometry while preserving the coating layer. By capturing precise measurements and generating structured data, they provide a more objective and repeatable approach to quality control.
In addition to defect detection, such systems offer valuable insights into process stability. Trends in dimensional variation can highlight inconsistencies in coating application or upstream processes, enabling proactive improvements.
Where StentSpect DC Fits In
Within this evolving inspection landscape, StentSpect DC is designed specifically for the evaluation of drug-coated stents. It enables non-contact inspection while measuring critical geometric parameters with high precision. By combining automated analysis with repeatable data output, it supports manufacturers in validating both coating integrity and structural consistency—without compromising the surface layer.